June 8, 2026 10:17 AM EDT News Briefing GSK inks multi-target liver pact with Engitix; Sangamo considers strategic options ENDPOINTS Plus news about Pfizer’s latest label expansion. 🤝 GSK inks multi-target liver pact with Engitix: London-based Engitix will use disease models … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
76 words · extracted 1mo agoread original ↗
comments(0)
5-min edit window · permanent after that